Kelley J L, Linn J A, Selway J W
Division of Organic Chemistry, Burroughs Wellcome Co., Research Triangle Park, North Carolina 27709.
J Med Chem. 1989 Aug;32(8):1757-63. doi: 10.1021/jm00128a016.
A series of 6-(dimethylamino)-2-(trifluoromethyl)-9-(substituted benzyl)purines was synthesized and tested for antirhinovirus activity. Most of the compounds were synthesized by alkylation of 6-chloro-2-(trifluoromethyl)-9H-purine with the appropriate benzyl halide followed by displacement of the chloro group with dimethylamine. Alternatively, 6-(dimethylamino)-2-(trifluoromethyl)purine was alkylated with the appropriate benzyl halide. Although several different aryl substituents provided compounds with IC50's = 0.03 microM against rhinovirus serotype 1B, no congener was significantly more active than the parent 2. Twenty-three compounds were tested against 18 other serotypes, but none exhibited a uniform profile of activity.
合成了一系列6-(二甲基氨基)-2-(三氟甲基)-9-(取代苄基)嘌呤,并测试了其抗鼻病毒活性。大多数化合物是通过6-氯-2-(三氟甲基)-9H-嘌呤与适当的苄基卤进行烷基化反应,然后用二甲胺取代氯原子来合成的。或者,6-(二甲基氨基)-2-(三氟甲基)嘌呤与适当的苄基卤进行烷基化反应。尽管几种不同的芳基取代基提供了对鼻病毒1B型IC50 = 0.03 microM的化合物,但没有同系物比母体2活性显著更高。对23种化合物针对其他18种血清型进行了测试,但没有一种表现出一致的活性特征。